Document is current
Any future updates will be listed below
-
Authors
Velz, Julia https://orcid.org/0000-0001-8027-9918
Freudenmann, Lena K. https://orcid.org/0000-0002-9827-4979
Medici, Gioele https://orcid.org/0000-0003-2279-6014
Dubbelaar, Marissa https://orcid.org/0000-0002-4930-1467
Mohme, Malte https://orcid.org/0000-0003-0627-9092
Ghasemi, David R. https://orcid.org/0000-0002-3844-9933
Scheid, Jonas https://orcid.org/0000-0002-5923-1343
Kowalewski, Daniel J. https://orcid.org/0000-0003-0482-9927
Patterson, Angelica B.
Zeitlberger, Anna M.
Lamszus, Katrin
Westphal, Manfred
Eyrich, Matthias https://orcid.org/0000-0002-8099-5903
Messing-Jünger, Martina
Röhrig, Andreas
Reinhard, Harald
Beccaria, Kévin
Craveiro, Rogeiro B.
Frey, Beat M. https://orcid.org/0000-0002-2514-8621
Sill, Martin https://orcid.org/0000-0001-7616-7665
Nahnsen, Sven https://orcid.org/0000-0002-4375-0691
Gauder, Marie https://orcid.org/0000-0001-8329-6924
Kapolou, Konstantina
Silginer, Manuela
Weiss, Tobias https://orcid.org/0000-0002-5533-9429
Wirsching, Hans-Georg https://orcid.org/0000-0001-6254-4204
Roth, Patrick
Grotzer, Michael
Krayenbühl, Niklaus https://orcid.org/0000-0003-1089-221X
Bozinov, Oliver
Regli, Luca https://orcid.org/0000-0003-4639-4474
Rammensee, Hans-Georg https://orcid.org/0000-0003-1614-2647
Rushing, Elisabeth J. https://orcid.org/0000-0001-7616-6320
Sahm, Felix https://orcid.org/0000-0001-5441-1962
Walz, Juliane S. https://orcid.org/0000-0001-6404-7391
Weller, Michael https://orcid.org/0000-0002-1748-174X
Neidert, Marian C.
- License Information
-
More Information
Article History
Received: 15 May 2023
Accepted: 14 January 2025
First Online: 4 February 2025
Competing interests
: L.K.F. and D.J.K. are employees, and H.G.R. is a shareholder of Immatics Biotechnologies GmbH. H.G.R. is also a shareholder of Curevac AG and ViferaXS GmbH. K.K. is currently an employee of Roche Diagnostics International Ltd and holds non-voting equity securities in F. Hoffmann-La Roche Ltd. G.M. is currently an employee of Roche Diagnostics International Ltd. M.M.J. received honoraria from Integra. T.W. has received honoraria for advisory board participation from Philogen and a research grant from Cellis. P.R. has received honoraria for lectures or advisory board participation from Bristol-Myers Squibb, Boehringer Ingelheim, Debiopharm, Merck Sharp and Dohme, Novocure, QED, and Roche and research support from Merck Sharp and Dohme and Novocure. FS received honoraria from Bayer and Illumina. F.S. is Co-founder and shareholder of Heildeberg Epignostix GmbH. Mi.W. has received research grants from Quercis and Versameb, and honoraria for lectures or advisory board participation or consulting from Novartis, Novocure, Orbus, and Philogen. M.C.N. has received a research grant from Novocure, honoraria for consulting, or lectures from WISE and MSD and Osteopore. The other authors declare no competing interests.
